PEN240517P220000
- 14.63
- 0.000.00%
Penumbra Newsroom
Penumbra Insider Sold Shares Worth $3,014,734, According to a Recent SEC Filing
Adam Elsesser, Director, Chief Executive Officer and President, on May 20, 2024, sold 15,000 shares in Penumbra (PEN) for $3,014,734. Following the Form 4 filing with the SEC, Elsesser has control ove
Penumbra(PEN.US) Officer Sells US$3.01 Million in Common Stock
$Penumbra(PEN.US)$ Officer Elsesser Adam sold 15,000 shares of common stock on May 20, 2024 at an average price of $200.98 for a total value of $3.01 million.Source: Announcement What is statement of
Penumbra, Inc.'s (NYSE:PEN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Penumbra (NYSE:PEN) has had a rough three months with its share price down 22%. However, stock prices are usually driven by a company's financials over the long term, which in this case look pretty
Form 144 | Penumbra(PEN.US) Insider Proposes to Sell 9.16 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 20, $Penumbra(PEN.US)$ Insider Adam Elsesser intends to sell 45,000 shares of its common stock on May 20, with a total market value of approximately $9.16 million. Sourc
Insider Sale: EVP, General Counsel & Secretary Johanna Roberts Sells 600 Shares of Penumbra ...
Penumbra(PEN.US) Officer Sells US$124.45K in Common Stock
$Penumbra(PEN.US)$ Officer Roberts Johanna sold 600 shares of common stock on May 13, 2024 at an average price of $207.41 for a total value of $124.45K.Source: Announcement What is statement of change
Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Call Transcript
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Price Target Cut to $272.00/Share From $284.00 by Canaccord Genuity
Penumbra Price Target Cut to $272.00/Share From $284.00 by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Penumbra, Lowers Price Target to $272
Penumbra Price Target Cut to $260.00/Share From $290.00 by Piper Sandler
Penumbra Price Target Cut to $260.00/Share From $290.00 by Piper Sandler
Penumbra Is Maintained at Overweight by Piper Sandler
Penumbra Is Maintained at Overweight by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Penumbra, Lowers Price Target to $260
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
The Latest Analyst Ratings For Penumbra
In the latest quarter, 7 analysts provided ratings for Penumbra (NYSE:PEN), showcasing a mix of bullish and bearish perspectives.The table below provides a concise overview of recent ratings by analys
Express News | Needham Reiterates Hold on Penumbra
Penumbra Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 — Needham Reiterates → Hold 04/03/2024 38.1% Piper Sandler $290 → $290 Reiterates Overweight →
Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating
Penumbra (PEN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $235 to $300.
Buy Rating Affirmed for Penumbra on Strong Q1 Performance and Robust Growth Prospects
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Repare Therapeutics (RPTX) and Penumbra (PEN)